Your browser doesn't support javascript.
loading
Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?
García-Alfonso, P; Feliú, J; García-Carbonero, R; Grávalos, C; Guillén-Ponce, C; Sastre, J; García-Foncillas, J.
Afiliação
  • García-Alfonso P; Medical Oncology Department, Gregorio Marañón University Hospital (Center Affiliated to the Red Tematica de Investigacion Cooperativa en Cancer [RTICC], Instituto Carlos III, Spanish Ministry of Science and Innovation), Madrid, Spain. pgarcaalfonso@gmail.com.
  • Feliú J; Medical Oncology Department, La Paz University Hospital, Madrid, Spain.
  • García-Carbonero R; Medical Oncology Department, Doce de Octubre University Hospital (Center Affiliated to the Red Tematica de Investigacion Cooperativa en Cancer [RTICC], Instituto Carlos III, Spanish Ministry of Science and Innovation), Madrid, Spain.
  • Grávalos C; Medical Oncology Department, Doce de Octubre University Hospital (Center Affiliated to the Red Tematica de Investigacion Cooperativa en Cancer [RTICC], Instituto Carlos III, Spanish Ministry of Science and Innovation), Madrid, Spain.
  • Guillén-Ponce C; Medical Oncology Department, Ramón y Cajal University Hospital (Center Affiliated to the Red Tematica de Investigacion Cooperativa en Cancer [RTICC], Instituto Carlos III, Spanish Ministry of Science and Innovation), Madrid, Spain.
  • Sastre J; Medical Oncology Department, Clinic San Carlos University Hospital (Center Affiliated to the Red Tematica de Investigacion Cooperativa en Cancer [RTICC], Instituto Carlos III, Spanish Ministry of Science and Innovation), Madrid, Spain.
  • García-Foncillas J; Oncology Department, Cancer Institute University Hospital (Fundacion Jimenez Diaz), Autonomous University of Madrid, Madrid, Spain.
Clin Transl Oncol ; 18(11): 1072-1081, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27037815
Assuntos
Palavras-chave
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Colorretais / Terapia de Salvação / Antineoplásicos Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha País de publicação: Itália
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Colorretais / Terapia de Salvação / Antineoplásicos Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha País de publicação: Itália